Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.35 - $0.56 $420 - $672
1,200 New
1,200 $0
Q4 2022

Feb 14, 2023

SELL
$0.41 - $18.6 $2,501 - $113,460
-6,100 Reduced 33.15%
12,300 $5,000
Q3 2022

Nov 14, 2022

SELL
$0.57 - $34.65 $18,639 - $1.13 Million
-32,700 Reduced 63.99%
18,400 $16,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $88.3M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.